AU6260796A - Isolated formylated bacterial peptides, nucleic acid molecul es and uses thereof - Google Patents

Isolated formylated bacterial peptides, nucleic acid molecul es and uses thereof

Info

Publication number
AU6260796A
AU6260796A AU62607/96A AU6260796A AU6260796A AU 6260796 A AU6260796 A AU 6260796A AU 62607/96 A AU62607/96 A AU 62607/96A AU 6260796 A AU6260796 A AU 6260796A AU 6260796 A AU6260796 A AU 6260796A
Authority
AU
Australia
Prior art keywords
isolated
nucleic acid
bacterial peptides
formylated
molecul
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU62607/96A
Inventor
Steve W. Dow
Ian M. Orme
Terence A. Potter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Jewish Health
Original Assignee
NAT JEWISH CENTER FOR IMMUNOLOGY AND RESPIRATORY MEDICINE
National Jewish Center for Immunology and Respiratory Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NAT JEWISH CENTER FOR IMMUNOLOGY AND RESPIRATORY MEDICINE, National Jewish Center for Immunology and Respiratory Medicine filed Critical NAT JEWISH CENTER FOR IMMUNOLOGY AND RESPIRATORY MEDICINE
Publication of AU6260796A publication Critical patent/AU6260796A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterized by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4615—Dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
    • A61K39/4622—Antigen presenting cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4646—Small organic molecules e.g. cocaine or nicotine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU62607/96A 1995-06-07 1996-06-05 Isolated formylated bacterial peptides, nucleic acid molecul es and uses thereof Abandoned AU6260796A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48416995A 1995-06-07 1995-06-07
US484169 1995-06-07
PCT/US1996/009473 WO1996040236A1 (en) 1995-06-07 1996-06-05 Isolated formylated bacterial peptides, nucleic acid molecules and uses thereof

Publications (1)

Publication Number Publication Date
AU6260796A true AU6260796A (en) 1996-12-30

Family

ID=23923040

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62607/96A Abandoned AU6260796A (en) 1995-06-07 1996-06-05 Isolated formylated bacterial peptides, nucleic acid molecul es and uses thereof

Country Status (2)

Country Link
AU (1) AU6260796A (en)
WO (1) WO1996040236A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1194670C (en) 1998-02-06 2005-03-30 日本Bcg制造株式会社 methods and compositions for detection and diagnosis of infectious diseases
EP1852126B1 (en) * 2001-03-27 2013-05-15 Oncothyreon Inc. Vaccine for modulating between T1 and T2 immune responses
JP2004533421A (en) 2001-03-27 2004-11-04 バイオミラ，インコーポレイテッド Vaccine for modulating between T1 and T2 immune responses
TWI395591B (en) 2004-04-01 2013-05-11 Oncothyreon Inc Mucinous glycoprotein (muc-1) vaccine
PT1896051E (en) 2005-06-28 2015-01-13 Oncothyreon Inc Method of treating patients with a mucinous glycoprotein (muc-1) vaccine
MX2013009742A (en) 2011-02-24 2014-01-31 Oncothyreon Inc Muc1 based glycolipopeptide vaccine with adjuvant.
WO2023282436A1 (en) * 2021-07-09 2023-01-12 포항공과대학교 산학협력단 Novel antigen peptide for preparation of formyl-methionine-specific antibody

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0499003A1 (en) * 1991-02-14 1992-08-19 N.V. Innogenetics S.A. Polypeptides and peptides, particularly recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnosis of tuberculosis
CA2096497A1 (en) * 1992-05-26 1993-11-27 Patricia Anne Spears Mycobacteria probes

Also Published As

Publication number Publication date
WO1996040236A1 (en) 1996-12-19

Similar Documents

Publication Publication Date Title
CA2258502A1 (en) Modified factor viii
AU2086199A (en) Plant uridine diphosphate-glucose dehydrogenase genes, proteins, and uses thereof
AU1226297A (en) Basic protein composition, basic peptide composition and application thereof
AU8826598A (en) Surface-bound, double-stranded dna protein arrays
AUPN999096A0 (en) Peptides, antibodies, vaccines & uses thereof
AU7214796A (en) Novel amino acid derivatives, their preparation and use
AU1889797A (en) Nucleic acid sequence detection
AU2978697A (en) Novel peptide, process for the production of the same, and use of the same
AU6244296A (en) Novel beta-xylosidase, nucleotide sequence encoding it, and use thereof
AU5800696A (en) Rhesus ob protein and dna
AU8620698A (en) Antifreeze proteins, dna and expression systems
AU1870597A (en) Nucleic acid sequences of genes of the high mobility group proteins and uses thereof
AU6410099A (en) (moraxella catarrhalis) protein, nucleic acid sequence and uses thereof
AU6260796A (en) Isolated formylated bacterial peptides, nucleic acid molecul es and uses thereof
AU3670395A (en) Hippocampus-associated proteins, dna sequences coding therefor and uses thereof
AU1137699A (en) Novel reovirus-derived proteins, nucleic acids encoding same, and uses therefor
AU5369396A (en) Rest protein and dna
AU4483696A (en) Novel peptides, their production and use
AU1142297A (en) Rna polymerase ii carboxyl terminal domain-derived peptides
AU6483896A (en) Nucleotide and amino acid sequence and uses thereof
AU5137698A (en) Novel dna, novel protein, and novel antibody
AU1525499A (en) Ikap proteins, nucleic acids and methods
AU5545896A (en) H. Influenzae HxuB and HxuC genes, proteins and methods of use
AU4219397A (en) Novel protein, its production and use
AU2801597A (en) Flea protease proteins, nucleic acid molecules, and uses thereof